DCT Planning Checklist:Your Guide to Ensuring a Successful Decentralized or Hybrid Trial

Executive Summary

Even before the COVID-19 pandemic spotlighted the benefits of decentralized clinical trials (DCTs), their use was becoming more commonplace. After witnessing the ability of DCTs to rescue a number of clinical trials that were in jeopardy as a result of participants being unwilling or unable to safely travel to clinical sites, more sponsors and CROs are taking note of how a mobile approach could benefit their trials

Whether used exclusively or as part of a hybrid approach in conjunction with traditional trial methods at clinical sites, the patient-centric nature of DCTs can enable investigators to more easily recruit and retain a diverse patient population. DCTs can’t, however, yield their full spectrum of advantages if not implemented with the proper planning and attention to detail.